CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1720080
Corrigendum: Editorial: Role of Extracellular Vesicles in Cancer: Implications in Immunotherapeutic Resistance
Provisionally accepted
- 1IRCCS Istituto Nazionale Tumori Regina Elena UOSD Immunologia e Immunoterapia dei Tumori, Rome, Italy, rome, Italy
- 2Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, Jharkhand, India, Deoghar, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: Exosomes, Nanoparticles, personalized medicine, tumor, Dendritic Cells, CD8 T cells, Oncoimmunology, crosstalk
Received: 07 Oct 2025; Accepted: 14 Oct 2025.
Copyright: © 2025 Spada and Ganguly. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Sheila Spada, sheilaspada88@gmail.com
Anirban Ganguly, anirban.biochemistry@aiimsdeoghar.edu.in
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.